EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 217 filers reported holding EDITAS MEDICINE INC in Q2 2018. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $782,000 | -23.7% | 24,580 | -14.1% | 0.00% | -33.3% |
| Q2 2018 | $1,025,000 | +10.3% | 28,609 | +2.1% | 0.00% | 0.0% |
| Q1 2018 | $929,000 | -8.1% | 28,017 | -14.8% | 0.00% | 0.0% |
| Q4 2017 | $1,011,000 | -46.2% | 32,900 | -58.0% | 0.00% | -50.0% |
| Q3 2017 | $1,880,000 | +43.1% | 78,300 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $1,314,000 | – | 78,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |